Spontaneous Orofacial Movements Induced in Rodents by Very Long-term Neuroleptic Drug Administration: Phenomenology, Pathophysiology and Putative Relationship to Tardive Dyskinesia

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 1990 Jan 1

PMID 1975104

Citations 37

Authors

J L Waddington

Affiliations

Soon will be listed here.

Abstract

While understanding of the major clinical and ethical issue of tardive dyskinesia would be greatly facilitated by the development of an isomorphic or homologous animal model, particularly in rodents, this has proved to be a highly contentious issue. The literature on orofacial function in rats administered neuroleptic drugs for substantial proportions of their adult lifespan is reviewed. It reveals the emergence of late-onset orofacial movements in a number of studies, but very early-onset movements or no effect in others. Potential explanations for these discrepancies are considered, and ways of resolving such inconsistencies are suggested. The relationship of these various orofacial phenomena to dopaminergic and non-dopaminergic function, and to clinical syndromes, is critically evaluated.

Citing Articles

The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation.

Velickovic U, Selakovic D, Jovicic N, Mitrovic M, Janjic V, Rosic S Biomedicines. 2025; 13(2).

PMID: 40002925 PMC: 11853207. DOI: 10.3390/biomedicines13020512.

California mice (Peromyscus californicus) adjust mouth movements for vocal production during early postnatal development.

Preston K, Riede T BMC Biol. 2024; 22(1):299.

PMID: 39719564 PMC: 11669224. DOI: 10.1186/s12915-024-02098-3.

Historical developments, hotspots, and trends in tardive dyskinesia research: a scientometric analysis of 54 years of publications.

Baminiwatta A, Correll C Front Psychiatry. 2023; 14:1194222.

PMID: 37333928 PMC: 10272363. DOI: 10.3389/fpsyt.2023.1194222.

A Subset of Purposeless Oral Movements Triggered by Dopaminergic Agonists Is Modulated by 5-HT Receptors in Rats: Implication of the Subthalamic Nucleus.

Lagiere M, Bosc M, Whitestone S, Benazzouz A, Chagraoui A, Millan M Int J Mol Sci. 2020; 21(22).

PMID: 33198169 PMC: 7698107. DOI: 10.3390/ijms21228509.

Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.

Estevez-Fraga C, Zeun P, Lopez-Sendon Moreno J Drugs Aging. 2018; 35(11):959-971.

PMID: 30357723 DOI: 10.1007/s40266-018-0590-y.

References

Kane J, Smith J . Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry. 1982; 39(4):473-81. DOI: 10.1001/archpsyc.1982.04290040069010. View

Levin E, Galen D, Ellison G . Chronic haloperidol effects on oral movements and radial-arm maze performance in rats. Pharmacol Biochem Behav. 1987; 26(1):1-6. DOI: 10.1016/0091-3057(87)90523-5. View

Rodriguez L, Moss D, Reyes E, Camarena M . Perioral behaviors induced by cholinesterase inhibitors: a controversial animal model. Pharmacol Biochem Behav. 1986; 25(6):1217-21. DOI: 10.1016/0091-3057(86)90115-2. View

Sant 3rd W, Ellison G . Drug holidays alter onset of oral movements in rats following chronic haloperidol. Biol Psychiatry. 1984; 19(1):95-9. View

Gunne L, Haggstrom J, Sjoquist B . Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature. 1984; 309(5966):347-9. DOI: 10.1038/309347a0. View

Rupniak M, Jenner P, Marsden C . The effect of chronic neuroleptic administration on cerebral dopamine receptor function. Life Sci. 1983; 32(20):2289-311. DOI: 10.1016/0024-3205(83)90759-2. View

Waddington J, Youssef H, Dolphin C, Kinsella A . Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality. Arch Gen Psychiatry. 1987; 44(10):907-12. DOI: 10.1001/archpsyc.1987.01800220077011. View

Rosengarten H, Schweitzer J, Friedhoff A . Induction of oral dyskinesias in naive rats by D1 stimulation. Life Sci. 1983; 33(25):2479-82. DOI: 10.1016/0024-3205(83)90155-8. View

Kane J, HONIGFELD G, Singer J, Meltzer H . Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988; 45(9):789-96. DOI: 10.1001/archpsyc.1988.01800330013001. View

10.

Perry T, Hansen S, Jones K . Schizophrenia, tardive dyskinesia, and brain GABA. Biol Psychiatry. 1989; 25(2):200-6. DOI: 10.1016/0006-3223(89)90164-9. View

11.

Rupniak N, Jenner P, Marsden C . Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats. Psychopharmacology (Berl). 1985; 85(1):71-9. DOI: 10.1007/BF00427326. View

12.

Waddington J, Youssef H, Molloy A, OBoyle K, Pugh M . Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies. J Clin Psychiatry. 1985; 46(4 Pt 2):29-33. View

13.

Andersson U, Haggstrom J, Levin E, Bondesson U, Valverius M, Gunne L . Reduced glutamate decarboxylase activity in the subthalamic nucleus in patients with tardive dyskinesia. Mov Disord. 1989; 4(1):37-46. DOI: 10.1002/mds.870040107. View

14.

Waddington J, Gamble S . Prolonged dopamine receptor blockade in rats after termination of long-term depot fluphenazine. Lancet. 1981; 1(8234):1375-6. DOI: 10.1016/s0140-6736(81)92558-7. View

15.

Rosengarten H, Schweitzer J, Egawa M, Friedhoff A . Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements. Adv Exp Med Biol. 1988; 235:159-67. DOI: 10.1007/978-1-4899-2723-1_11. View

16.

Rupniak N, Jenner P, Marsden C . Acute dystonia induced by neuroleptic drugs. Psychopharmacology (Berl). 1986; 88(4):403-19. DOI: 10.1007/BF00178501. View

17.

Waddington J, Molloy A . Duration of treatment relationships for involuntary movements (tardive dyskinesia): concordance between cross-sectional, clinical, and longitudinal animal studies?. Arch Gen Psychiatry. 1986; 43(2):191-2. DOI: 10.1001/archpsyc.1986.01800020101018. View

18.

Stone R, Alvarez W, May J . Dyskinesia, antipsychotic-drug exposure and risk factors in a developmentally-disabled population. Pharmacol Biochem Behav. 1988; 29(1):45-51. DOI: 10.1016/0091-3057(88)90271-7. View

19.

Lieberman J, Pollack S, Lesser M, Kane J . Pharmacologic characterization of tardive dyskinesia. J Clin Psychopharmacol. 1988; 8(4):254-60. View

20.

Waddington J, Molloy A . The status of late-onset vacuous chewing/perioral movements during long-term neuroleptic treatment in rodents: tardive dyskinesia or dystonia?. Psychopharmacology (Berl). 1987; 91(1):136-7. DOI: 10.1007/BF00690944. View